News & Updates

Increased serum levels of 25-hydroxyvitamin D (25[OH]D) show a significant association with genetically predicted chronic kidney disease (CKD), increased blood urea nitrogen (BUN), and decreased estimated glomerular filtration rate (eGFR), reports a Europe study. However, 25(OH)D appears to have no causal effect on renal function.

Use of cannabis among Singaporeans usually starts during teenage years, primarily because of peer influence, reveals a study. Later in life, these users may progress to other illicit drugs such as heroin.

A territory-wide, retrospective cohort study in Hong Kong has shown that molnupiravir and nirmatrelvir/ritonavir are effective in reducing the risks of hospitalization and inpatient disease progression among older patients residing in nursing homes.

Treatment with dapagliflozin leads to a reduction in the rate of total heart failure (HF) events and cardiovascular death, irrespective of patient characteristics such as ejection fraction (EF), according to data from the DELIVER* trial.

Treatment with dazodalibep, a novel nonantibody fusion protein that acts as an antagonist of CD40 ligand, significantly reduced symptom burden in adults with Sjögren’s syndrome, according to the ALISS trial presented at EULAR 2023.

In the treatment of chronic glucocorticoid users with high fracture risk, romosozumab yields higher gains in spine bone mineral density (BMD) compared with denosumab, as shown in a pilot trial presented at EULAR 2023.

Age-related accumulation of visceral adipose tissue (VAT) in both men and women may result in lower paraspinal muscle density, suggests a study.